Ji-Lin Cheng
Overview
Explore the profile of Ji-Lin Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Chen L, Wang Y, Lyu B, Zhao H, Shang Z, et al.
Chin Med J (Engl)
. 2020 Jun;
133(14):1639-1648.
PMID: 32568867
Background: The efficacy of entecavir (ETV) add-on peg-interferon therapy compared with ETV monotherapy in treatment-naïve hepatitis B virus (HBV) patients remains controversial. We investigated whether adding peg-interferon to ongoing ETV...
2.
Wu S, Liu L, Cheng J, Liu Y, Cheng L, Wang S, et al.
Clin Exp Med
. 2018 Apr;
18(3):433-443.
PMID: 29696462
The correlation between improvement in longitudinal liver stiffness and fibrosis regression has not been properly evaluated during long-term antiviral therapy in chronic hepatitis B (CHB) patients. In this study, liver...
3.
Cheng Y, Li D, Cheng X, Liu B, Cheng J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
. 2010 Apr;
23(5):321-4.
PMID: 20387474
Objective: To explore the distribution of cytomegalovirus (CMV) in vascular tissues and the relationship between virus and atherosclerogenesis after CMV infecting mice. Methods: (1) C57 BL/6J Murine model of CMV...
4.
Zhao J, Yang Y, You S, Jing Z, Wu Y, Cheng J, et al.
Coron Artery Dis
. 2006 Jul;
17(5):463-9.
PMID: 16845255
Background: Both fosinopril and valsartan are effective in protecting endothelial function. We hypothesized that they may also reduce myocardial no-reflow. In addition, suppression of adenosine triphosphate-sensitive K (KATP) channel opening...
5.
Wu J, Meng X, Chen Y, Cheng J, Li D, Lu H
Zhonghua Gan Zang Bing Za Zhi
. 2003 May;
11(5):315-7.
PMID: 12773256
No abstract available.
6.
Wei H, Lu H, Li D, Zhan Y, Wang Z, Huang X, et al.
World J Gastroenterol
. 2002 Jan;
6(6):824-828.
PMID: 11819703
AIM:To assess the effect of ACE inhibitor and Ang II type 1 (AT1) receptor antagonist in preventing hepatic fibrosis caused by CCl(4) administration in rats;to investigate whether or not there...
7.
Wei H, Li D, Lu H, Zhan Y, Wang Z, Huang X, et al.
World J Gastroenterol
. 2002 Jan;
6(4):540-545.
PMID: 11819643
AIM:To investigate effect of losartan, an AT1 receptor antagonist, on hepatic fibrosis induced by CCl(4); and to determine whether or not AT1 receptors are expressed on hepatic stellate cells. METHODS...